Literature DB >> 11937620

Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program.

Elise D Riley1, David Vlahov, Steven Huettner, Peter Beilenson, Margaret Bonds, Richard E Chaisson.   

Abstract

OBJECTIVE: To describe characteristics of needle-exchange program (NEP) participants who utilized tuberculosis services from an NEP site.
METHODS: Between June 1998 and May 1999, tuberculosis services were advertised and offered to Baltimore, Maryland, NEP participants. Demographic and tuberculosis-specific data were collected on participants who self-selected into services. Analyses were based on being tuberculin skin tested, returning for a skin test reading, and testing tuberculin positive.
RESULTS: Among 691 contacts with NEP participants, this service performed 296 tuberculin tests, with an 84% return rate for skin test reading. Participants were 32% female, 87% African American, and 11% employed. Higher frequency of NEP visits was positively associated with requesting tuberculosis services and returning for skin test reading. Among those who returned for skin test reading, longer smoking duration and problems getting food in the past year due to a lack of money were associated with a positive test.
CONCLUSIONS: Utilization of a tuberculosis service and high return rates can be achieved among NEP participants without formal recruitment strategies. Frequent exchange appears to facilitate return visits for NEP-based tuberculosis screening, which may imply accessibility for frequent exchangers. More extensive health services at sites of the Baltimore NEP appear to be warranted, with particular attention paid to effectiveness for frequent exchangers.

Entities:  

Mesh:

Year:  2002        PMID: 11937620      PMCID: PMC3456382          DOI: 10.1093/jurban/79.1.113

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  34 in total

1.  Monetary versus nonmonetary incentives for TB skin test reading among drug users.

Authors:  C K Malotte; J R Hollingshead; F Rhodes
Journal:  Am J Prev Med       Date:  1999-04       Impact factor: 5.043

2.  Multidrug-resistant tuberculosis.

Authors:  N Galai; N Graham; R Chaisson; K E Nelson; D Vlahov; J Lewis
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

3.  Eleven years of community-based directly observed therapy for tuberculosis.

Authors:  C P Chaulk; K Moore-Rice; R Rizzo; R E Chaisson
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

4.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.

Authors:  D Vlahov; B Junge; R Brookmeyer; S Cohn; E Riley; H Armenian; P Beilenson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-15

Review 5.  Respiratory complications of cocaine abuse.

Authors:  J A Perper; D H Van Thiel
Journal:  Recent Dev Alcohol       Date:  1992

6.  National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome.

Authors:  D R Burwen; A B Bloch; L D Griffin; C A Ciesielski; H A Stern; I M Onorato
Journal:  Arch Intern Med       Date:  1995-06-26

Review 7.  Medical care for injection-drug users with human immunodeficiency virus infection.

Authors:  P G O'Connor; P A Selwyn; R S Schottenfeld
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

8.  Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study.

Authors:  C A Latkin; A R Knowlton; D Hoover; W Mandell
Journal:  Am J Drug Alcohol Abuse       Date:  1999-08       Impact factor: 3.829

9.  Implications of directly observed therapy in tuberculosis control measures among IDUs.

Authors:  R Curtis; S R Friedman; A Neaigus; B Jose; M Goldstein; D C Des Jarlais
Journal:  Public Health Rep       Date:  1994 May-Jun       Impact factor: 2.792

10.  Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy.

Authors:  W R Bishai; N M Graham; S Harrington; D S Pope; N Hooper; J Astemborski; L Sheely; D Vlahov; G E Glass; R E Chaisson
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

View more
  11 in total

1.  Tuberculosis among Africans living in the United States, 2000-2009.

Authors:  Bisrat K Abraham; Carla A Winston; Elvin Magee; Roque Miramontes
Journal:  J Immigr Minor Health       Date:  2013-04

Review 2.  In the shadow of academic medical centers: a systematic review of urban health research in Baltimore City.

Authors:  Nadra C Tyus; M Christopher Gibbons; Karen A Robinson; Claire Twose; Bernard Guyer
Journal:  J Community Health       Date:  2010-08

3.  Tuberculosis report among injection drug users and their partners in Kazakhstan.

Authors:  S Hermosilla; N El-Bassel; A Aifah; A Terlikbayeva; Z Zhumadilov; K Berikkhanova; M Darisheva; L Gilbert; N Schluger; S Galea
Journal:  Public Health       Date:  2015-03-17       Impact factor: 2.427

4.  Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users.

Authors:  Jonathan E Golub; Jacquie Astemborski; Mohammed Ahmed; Wendy Cronin; Shruti H Mehta; Gregory D Kirk; David Vlahov; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

5.  Hunger and associated harms among injection drug users in an urban Canadian setting.

Authors:  Aranka Anema; Evan Wood; Sheri D Weiser; Jiezhi Qi; Julio Sg Montaner; Thomas Kerr
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-08-26

Review 6.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

7.  High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico.

Authors:  R S Garfein; R Lozada; L Liu; R Laniado-Laborin; T C Rodwell; R Deiss; J Alvelais; A Catanzaro; P G Chiles; S A Strathdee
Journal:  Int J Tuberc Lung Dis       Date:  2009-05       Impact factor: 2.373

8.  Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing.

Authors:  David C Perlman; Patricia Friedmann; Leslie Horn; Anne Nugent; Veronika Schoeb; Jeanne Carey; Nadim Salomon; Don C Des Jarlais
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

9.  Feasibility and willingness-to-pay for integrated community-based tuberculosis testing.

Authors:  Neela D Goswami; Emily Hecker; David P Holland; Susanna Naggie; Gary M Cox; Ann Mosher; Debbie Turner; Yvonne Torres; Carter Vickery; Marshall A Ahearn; Michela L M Blain; Petra Rasmussen; Jason E Stout
Journal:  BMC Infect Dis       Date:  2011-11-02       Impact factor: 3.090

10.  Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay.

Authors:  Puneet Kumar Dewan; Jennifer Grinsdale; Sally Liska; Ernest Wong; Robert Fallstad; L Masae Kawamura
Journal:  BMC Infect Dis       Date:  2006-03-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.